Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 269

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Drug-resistant tuberculosis: time for visionary political leadership

Open access
Abubakar, Ibrahim, Zignol, Matteo, Falzon, Dennis, Raviglione, Mario, Ditiu, Lucica, Masham, Susan, Adetifa, Ifedayo, Ford, Nathan, Cox, Helen, Lawn, Stephen D, Marais, Ben J, McHugh, Timothy D, Mwaba, Peter, Bates, Matthew, Lipman, Marc, Zijenah, Lynn, Logan, Simon, McNerney, Ruth, Zumla, Adam, Sarda, Krishna, Nahid, Payam, Hoelscher, Michael, Pletschette, Michel, Memish, Ziad A, Kim, Peter, Hafner, Richard, Cole, Stewart, Migliori, Giovanni Battista, Maeurer, Markus, Schito, Marco, Zumla, Alimuddin·2013·The Lancet Infectious Diseases

Abstract

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly cost-effective directly observed treatment short-course programme to control the epidemic. At that time, most strains of Mycobacterium tuberculosis were susceptible to first-line tuberculosis drugs, and drug resistance was not a major issue. However, in 2013, tuberculosis remains a major public health concern worldwide, with prevalence of multidrug-resistant (MDR) tuberculosis rising. WHO estimates roughly 630 000 cases of MDR tuberculosis worldwide, with great variation in the frequency of MDR tuberculosis between countries. In the past 8 years, extensively drug-resistant (XDR) tuberculosis has emerged, and has been reported in 84 countries, heralding the possibility of virtually untreatable tuberculosis. Increased population movement, the continuing HIV pandemic, and the rise in MDR tuberculosis pose formidable challenges to the global control of tuberculosis. We provide an overview of the global burden of drug-resistant disease; discuss the social, health service, management, and control issues that fuel and sustain the epidemic; and suggest specific recommendations for important next steps. Visionary political leadership is needed to curb the rise of MDR and XDR tuberculosis worldwide, through sustained funding and the implementation of global and regional action plans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(13)70030-6

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 269

Metadata

Authors
Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., Adetifa, I., Ford, N., Cox, H., Lawn, S. D., Marais, B. J., McHugh, T. D., Mwaba, P., Bates, M., Lipman, M., Zijenah, L., Logan, S., McNerney, R., Zumla, A., Sarda, K., Nahid, P., Hoelscher, M., Pletschette, M., Memish, Z. A., Kim, P., Hafner, R., Cole, S., Migliori, G. B., Maeurer, M., Schito, M., & Zumla, A.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2013-06
Volume
13
Issue
6
Pages
529-539
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2115752666
Cited by
269
References
58
FWCI
31.41
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-resistant tuberculosis: time for visionary political leadership. https://app.cochat.ai/papers/10.1016/s1473-3099(13)70030-6
The paper
Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., Adetifa, I., Ford, N., Cox, H., Lawn, S. D., Marais, B. J., McHugh, T. D., Mwaba, P., Bates, M., Lipman, M., Zijenah, L., Logan, S., McNerney, R., Zumla, A., . . . Zumla, A. (2013). Drug-resistant tuberculosis: time for visionary political leadership. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(13)70030-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.